IHE

Alternative ETFs

ETFs Nearly Erase Friday’s Losses

By Tom LydonFebruary 1, 2011

Featured

Pharmaceutical ETFs Look to the Future

By Tom LydonJanuary 29, 2011

Featured

Health Care ETFs Jump As Changes Kick In

By Tom LydonJanuary 4, 2011

Featured

Play the Booming Biotech Sector With ETFs

By Tom LydonDecember 21, 2010

Featured

Pharmaceutical ETFs: Drug Companies Roar Back

By Tom LydonNovember 16, 2010

Featured

Pharma ETFs Find New Avenues of Growth

By Tom LydonOctober 8, 2010

Equity ETFs

Health Care ETFs: Next Up, Emerging Markets

By Tom LydonAugust 30, 2010

Featured

ETFs for a Changing Pharma Landscape

By Tom LydonAugust 5, 2010

Alternative ETFs

ETFs Fall While Unemployment Claims Rise

By Tom LydonJune 17, 2010

Featured

The Bulls May Prevail: Pharmaceutical ETFs

By Tom LydonMay 13, 2010

Featured

ETFs Listless as Goldman Fallout Continues

By Tom LydonApril 19, 2010

Featured

Health Care Reform ETF Winners and Losers

By Tom LydonApril 5, 2010

Featured

Which ETFs Were Spurned By the Health Care Bill?

By Tom LydonDecember 22, 2009

Featured

Emerging Markets: The Next Big Driver of Pharmaceutical, Biotech ETFs?

By Tom LydonDecember 15, 2009

Featured

ETFs to Play Obama’s New Policies

By Tom LydonNovember 13, 2009

Equity ETFs

Midday Market Update: Economic Data Pauses Stocks, ETFs

By Tom LydonOctober 20, 2009

Alternative ETFs

Midday Market Update: Stocks, ETFs Slip Following Earnings

By Tom LydonOctober 13, 2009

Featured

How the Race for a Cancer Drug Could Help Pharmaceutical ETFs

By Tom LydonSeptember 7, 2009

Previous 1 2 3 4 5 Next